P20917
Gene name |
Mag |
Protein name |
Myelin-associated glycoprotein |
Names |
Siglec-4a |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:17136 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
28 variants for P20917
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs3388899545 | 21 | H>Q | No | EVA | |
| rs3388873230 | 24 | A>D | No | EVA | |
| rs3388898818 | 135 | L>M | No | EVA | |
| rs3397339331 | 165 | C>* | No | EVA | |
| rs3412177956 | 165 | C>G | No | EVA | |
| rs3397795215 | 224 | T>I | No | EVA | |
| rs3388899591 | 226 | L>* | No | EVA | |
| rs261533695 | 281 | R>K | No | EVA | |
| rs49440298 | 286 | K>E | No | EVA | |
| rs3388893289 | 302 | V>I | No | EVA | |
| rs3388902685 | 325 | A>T | No | EVA | |
| rs3388902663 | 330 | T>I | No | EVA | |
| rs3388899573 | 336 | V>M | No | EVA | |
| rs3388886813 | 414 | I>K | No | EVA | |
| rs3388873277 | 419 | S>* | No | EVA | |
| rs3388882433 | 425 | R>I | No | EVA | |
| rs3388882451 | 428 | V>L | No | EVA | |
| rs3388873271 | 481 | Q>* | No | EVA | |
| rs3388896115 | 502 | P>L | No | EVA | |
| rs3388902716 | 504 | Q>H | No | EVA | |
| rs3388898746 | 518 | G>C | No | EVA | |
| rs47451860 | 546 | S>P | No | EVA | |
| rs3388858429 | 555 | H>L | No | EVA | |
| rs3397330721 | 570 | K>Q | No | EVA | |
| rs3397574851 | 571 | Y>S | No | EVA | |
| rs45996260 | 574 | E>K | No | EVA | |
| rs227369433 | 591 | S>P | No | EVA | |
| rs3388897102 | 607 | P>S | No | EVA |
No associated diseases with P20917
9 regional properties for P20917
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | Immunoglobulin subtype 2 | 252 - 312 | IPR003598-1 |
| domain | Immunoglobulin subtype 2 | 338 - 399 | IPR003598-2 |
| domain | Immunoglobulin subtype | 27 - 135 | IPR003599-1 |
| domain | Immunoglobulin subtype | 144 - 237 | IPR003599-2 |
| domain | Immunoglobulin subtype | 246 - 323 | IPR003599-3 |
| domain | Immunoglobulin subtype | 332 - 410 | IPR003599-4 |
| domain | Immunoglobulin-like domain | 239 - 321 | IPR007110-1 |
| domain | Immunoglobulin-like domain | 329 - 408 | IPR007110-2 |
| domain | CD80-like, immunoglobulin C2-set | 142 - 219 | IPR013162 |
10 GO annotations of cellular component
| Name | Definition |
|---|---|
| compact myelin | The portion of the myelin sheath in which layers of cell membrane are tightly juxtaposed, completely excluding cytoplasm. The juxtaposed cytoplasmic surfaces form the major dense line, while the juxtaposed extracellular surfaces form the interperiod line visible in electron micrographs. |
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| integral component of plasma membrane | The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| membrane raft | Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions. |
| mesaxon | Portion of the ensheathing process (either myelin or non-myelin) where the enveloping lips of the ensheathing cell come together so that their apposed plasma membranes run parallel to each other, separated by a cleft 12 nm wide. |
| myelin sheath | An electrically insulating fatty layer that surrounds the axons of many neurons. It is an outgrowth of glial cells: Schwann cells supply the myelin for peripheral neurons while oligodendrocytes supply it to those of the central nervous system. |
| myelin sheath adaxonal region | The region of the myelin sheath nearest to the axon. |
| paranode region of axon | An axon part that is located adjacent to the nodes of Ranvier and surrounded by lateral loop portions of myelin sheath. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| Schmidt-Lanterman incisure | Regions within compact myelin in which the cytoplasmic faces of the enveloping myelin sheath are not tightly juxtaposed, and include cytoplasm from the cell responsible for making the myelin. Schmidt-Lanterman incisures occur in the compact myelin internode, while lateral loops are analogous structures found in the paranodal region adjacent to the nodes of Ranvier. |
6 GO annotations of molecular function
| Name | Definition |
|---|---|
| carbohydrate binding | Binding to a carbohydrate, which includes monosaccharides, oligosaccharides and polysaccharides as well as substances derived from monosaccharides by reduction of the carbonyl group (alditols), by oxidation of one or more hydroxy groups to afford the corresponding aldehydes, ketones, or carboxylic acids, or by replacement of one or more hydroxy group(s) by a hydrogen atom. Cyclitols are generally not regarded as carbohydrates. |
| ganglioside GT1b binding | Binding to ganglioside GT1b. |
| protein homodimerization activity | Binding to an identical protein to form a homodimer. |
| protein kinase binding | Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
| sialic acid binding | Binding to a sialic acid, a N- or O- substituted derivative of neuraminic acid, a nine carbon monosaccharide. Sialic acids often occur in polysaccharides, glycoproteins, and glycolipids in animals and bacteria. |
| signaling receptor binding | Binding to one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function. |
14 GO annotations of biological process
| Name | Definition |
|---|---|
| axon regeneration | The regrowth of axons following their loss or damage. |
| cell adhesion | The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules. |
| cell-cell adhesion via plasma-membrane adhesion molecules | The attachment of one cell to another cell via adhesion molecules that are at least partially embedded in the plasma membrane. |
| cellular response to mechanical stimulus | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. |
| central nervous system myelin formation | The process in which the wraps of cell membrane that constitute myelin are laid down around an axon by an oligodendrocyte in the central nervous system. |
| central nervous system myelination | The process in which neuronal axons and dendrites become coated with a segmented lipid-rich sheath (myelin) to enable faster and more energetically efficient conduction of electrical impulses. The sheath is formed by the cell membranes of oligodendrocytes in the central nervous system. Adjacent myelin segments are separated by a non-myelinated stretch of axon called a node of Ranvier. |
| myelination | The process in which myelin sheaths are formed and maintained around neurons. Oligodendrocytes in the brain and spinal cord and Schwann cells in the peripheral nervous system wrap axons with compact layers of their plasma membrane. Adjacent myelin segments are separated by a non-myelinated stretch of axon called a node of Ranvier. |
| negative regulation of axon extension | Any process that stops, prevents, or reduces the frequency, rate or extent of axon outgrowth. |
| negative regulation of neuron apoptotic process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons. |
| negative regulation of neuron differentiation | Any process that stops, prevents, or reduces the frequency, rate or extent of neuron differentiation. |
| negative regulation of neuron projection development | Any process that decreases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites). |
| positive regulation of astrocyte differentiation | Any process that activates or increases the frequency, rate or extent of astrocyte differentiation. |
| positive regulation of myelination | Any process that activates or increases the frequency, rate or extent of the formation of a myelin sheath around nerve axons. |
| transmission of nerve impulse | The neurological system process in which a signal is transmitted through the nervous system by a combination of action potential propagation and synaptic transmission. |
1 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| P20916 | MAG | Myelin-associated glycoprotein | Homo sapiens (Human) | PR |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MIFLATLPLF | WIMISASRGG | HWGAWMPSTI | SAFEGTCVSI | PCRFDFPDEL | RPAVVHGVWY |
| 70 | 80 | 90 | 100 | 110 | 120 |
| FNSPYPKNYP | PVVFKSRTQV | VHESFQGRSR | LLGDLGLRNC | TLLLSTLSPE | LGGKYYFRGD |
| 130 | 140 | 150 | 160 | 170 | 180 |
| LGGYNQYTFS | EHSVLDIVNT | PNIVVPPEVV | AGTEVEVSCM | VPDNCPELRP | ELSWLGHEGL |
| 190 | 200 | 210 | 220 | 230 | 240 |
| GEPTVLGRLR | EDEGTWVQVS | LLHFVPTREA | NGHRLGCQAA | FPNTTLQFEG | YASLDVKYPP |
| 250 | 260 | 270 | 280 | 290 | 300 |
| VIVEMNSSVE | AIEGSHVSLL | CGADSNPPPL | LTWMRDGMVL | REAVAKSLYL | DLEEVTPGED |
| 310 | 320 | 330 | 340 | 350 | 360 |
| GVYACLAENA | YGQDNRTVEL | SVMYAPWKPT | VNGTVVAVEG | ETVSILCSTQ | SNPDPILTIF |
| 370 | 380 | 390 | 400 | 410 | 420 |
| KEKQILATVI | YESQLQLELP | AVTPEDDGEY | WCVAENQYGQ | RATAFNLSVE | FAPIILLESH |
| 430 | 440 | 450 | 460 | 470 | 480 |
| CAAARDTVQC | LCVVKSNPEP | SVAFELPSRN | VTVNETEREF | VYSERSGLLL | TSILTIRGQA |
| 490 | 500 | 510 | 520 | 530 | 540 |
| QAPPRVICTS | RNLYGTQSLE | LPFQGAHRLM | WAKIGPVGAV | VAFAILIAIV | CYITQTRRKK |
| 550 | 560 | 570 | 580 | 590 | 600 |
| NVTESSSFSG | GDNPHVLYSP | EFRISGAPDK | YESEKQRLGS | ERRLLGLRGE | SPELDLSYSH |
| 610 | 620 | ||||
| SDLGKRPTKD | SYTLTEELAE | YAEIRVK |